Normal Cells of Patients with High Cancer Risk Syndromes Lack Transforming Activity in the NIH/3T3 Transfection Assay
- 14 October 1983
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 222 (4620) , 173-175
- https://doi.org/10.1126/science.6623066
Abstract
Oncogenes capable of transforming NIH/3T3 cells are often present in human tumors and tumor cell lines. Such oncogenes were not detected in normal fibroblast lines derived from patients with several clinical syndromes associated with greatly increased cancer risk. Thus, germ-line transmission of these oncogenes does not appear to be the predisposing factor responsible for these high cancer risk syndromes.This publication has 33 references indexed in Scilit:
- Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogeneNature, 1983
- Retraction of Data on the Human c- ras 1 H OncogeneScience, 1983
- The Human c- ras 1 H Oncogene: a Mutation in Normal and Neoplastic Tissue from the Same PatientScience, 1983
- The use of a tumor promoter for the detection of individuals with the gardner syndromeCancer, 1983
- Mouse c-myc Oncogene Is Located on Chromosome 15 and Translocated to Chromosome 12 in PlasmacytomasScience, 1982
- Activation of a cellular oncogene by DNA rearrangement: possible involvement of an IS-like elementNature, 1982
- Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras geneNature, 1982
- Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cellsNature, 1982
- Three different human tumor cell lines contain different oncogenesCell, 1981
- Differential genetic susceptibility of cultured human skin fibroblasts to transformation by Kirsten murine sarcoma virusCell, 1977